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Edited by Ned ManteiAbstract ATP is an excitatory neurotransmitter in the central
and peripheral nervous system. We investigated ATP accumula-
tion in highly puriﬁed brain synaptic vesicles (SVs). Based on the
amount of ATP accumulated in SVs under the conditions used,
ATP is not transported against a concentration gradient but
rather appears to have a DlH+-independent mechanism. ATP
transport was inhibited by DIDS and NEM, but was not aﬀected
by Mg2+ or by pre-incubation with nucleotides. These results
suggest a unique transport mechanism that does not involve ex-
change with other nucleotides or protons, unlike other known
neurotransmitter transport systems.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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ATP has been shown to act as a fast excitatory transmitter in
the central nervous system [1,2], in the peripheral nervous sys-
tem [3–6] and in chromaﬃn cells [7]. In most cells, including
cells that rely on ATP as a neurotransmitter, ATP in the cyto-
sol reaches a concentration of 1.7 mM [8]. As demonstrated
by [31P]NMR, isolated cholinergic synaptic vesicles (SVs) from
Torpedo marmorata contain about 0.2 M ATP in solution,
which is retained during SV isolation [9]. Thus, the ATP con-
centration in SVs is about 100-fold higher than in the cyto-
plasm [10–12]. Since ATP, therefore, would have to be
transferred into the SV lumen against its concentration gradi-
ent, it was assumed that an ATP transporter in the SVs was re-
quired. To date, however, eﬀorts to identify such a transporter
have met no success.
Vesicular transport has been studied for several classical
neurotransmitters, including acetylcholine [13], amines [14],
glutamate [15], GABA [16] and glycine [17], all of which couple
the uptake of the neurotransmitter against its concentration
gradient to H+ eﬄux. Moreover, several neurotransmitter*Corresponding author. Fax: +972 8 6472992.
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eties. Putransporters have been cloned, puriﬁed, characterized and
reconstituted into liposomes allowing for detailed study
[18,19]. Surprisingly, no synaptic vesicle ATP transporter is in-
cluded in this list.
In this study, ATP transport into highly puriﬁed sheep brain
SVs was characterized with respect to nucleotide speciﬁcity,
inhibitor sensitivity and underlying mechanism. The results
indicate that the ATP transport into synaptic vesicles can be
distinguished from other neurotransmitters transport systems
in terms of its mechanism and energy requirements.2. Materials and methods
2.1. Materials
All reagents except those speciﬁed below were obtained from Sigma
(St. Louis, MO). Anti-synaptophysin monoclonal antibody was
obtained from Cal Biochem (Darmstadt, Germany). Synthetic ﬁreﬂy
D-luciferin was purchased from Biosynth (Staad, Switzerland).
[a-32P]BzATP was synthesized and puriﬁed essentially as described
previously [20]. [a-32P]ATP was obtained from Amersham Biosciences.
2.2. Synaptic vesicle preparation
Synaptic vesicles were prepared from freshly dissected sheep brain
synaptosomes as described [21], with a fewmodiﬁcations. Brieﬂy, whole
brain was homogenized in 0.32 M sucrose, 10 mM HEPES, pH 7.4,
with added protease inhibitors, and then centrifuged at 800 · g for
10 min. The supernatant was centrifuged at 9200 · g for 15 min. The
9200 · g pellet was resuspended in the same buﬀer and centrifuged
again at 10200 · g for 15 min and the obtained pellet was resuspended
to yield the synaptosomal fraction (P2). P2 was lysed hypotonically by a
10-fold dilution in 5 mM HEPES, pH 7.4, containing protease inhibi-
tors and incubated 30 min on ice, then centrifuged at 25,000 · g for
20 min. The supernatant was centrifuged at 160,000 · g for 2 h to yield
a crude synaptic vesicle fraction (LP2) that was then layered on a 10–
50% (vol/vol) glycerol step gradient and centrifuged at 100,000 · g for
5 h. Puriﬁed SVs were collected from the 40% glycerol layer.
2.3. ATP transport assay
Synaptic vesicles (1 mg/ml) were incubated for 0.5–30 min at room
temperature with diﬀerent concentrations of [a-32P]ATP (500–
1000 cpm/pmol) in a buﬀer containing 150 mM KCl and 10 mM
HEPES, pH 7.4. ATP transport was terminated by addition of 4,4 0-
diisothiocyanostilbene-2,20-disulfonic acid (DIDS) to a ﬁnal concen-
tration of 1 mM and incubation at room temperature for 10 min,
followed by the addition of a 10-fold excess of unlabeled ATP. Samples
(0.15 ml each) were then subjected to chromatography–centrifugation
to separate SVs from other reagents [22] using 1 ml Sephadex G-50 col-
umns equilibrated with 0.32 M sucrose, 10 mM HEPES, pH 7.4. The
columns were centrifuged for 3 min at 700 · g followed by sample
loading. Elution from the dried column was achieved by centrifugation
for 3 min at 700 · g. Radioactivity in the vesicles was quantiﬁed by li-
quid scintillation counting. The Sephadex G-50 chromatography–cen-
trifugation procedure [22] was found to give in SVs ATP accumulationblished by Elsevier B.V. All rights reserved.
R. Zalk, V. Shoshan-Barmatz / FEBS Letters 580 (2006) 5894–5898 5895with low background and also ensures a rapid separation between free
and intra-vesicular ATP, thereby minimizing ATP eﬄux as compared
to other chromatography methods (such as ion exchange).
2.4. Determination of ATP content in the SVs
The ATP content of the synaptic vesicles was measured by the luci-
ferin/luciferase assay [23]. Synaptic vesicles were boiled, centrifuged
and supernatant aliquots were measured using a BioOrbit 1251 lumi-
nometer.
2.5. Photoaﬃnity labeling by [a-32P]BzATP
Membrane protein fractions (1 mg/ml) were irradiated with a 15-W
ultraviolet lamp for 3 min in the presence of 1–5 lM of [a-32P]BzATP
(4 · 106 to 107 cpm/nmol) in 40 ll of 20 mM Tricine, pH 7.4 and 0.1 M
NaCl. The irradiated samples were subjected to SDS–PAGE and
exposed to Kodak X-Omat ﬁlm.
2.6. Immunoblot analyses
Monoclonal anti-synaptophysin (1:5000), anti-VDAC (1:10000) or
anti-RyR (1:5000) antibodies were used followed by horseradish per-
oxidase (HRP)-conjugated goat anti-mouse IgG as a secondary anti-
body (1:7,000).3. Results
3.1. Puriﬁcation of SVs and labeling of ATP binding proteins
with [a-32P]BzATP
Highly puriﬁed SVs were ﬁrst isolated and characterized.
Since a transporter for ATP would be expected to possess an
ATP-binding site, a photoreactive ATP analog, 3 0-0-(4-benzo-
yl) benzoyl-5 0 ATP (BzATP), designed to interact covalentlyFig. 1. Characterization of brain synaptic vesicles. Synaptosomes (P2), crud
ranging from 20% to 50% (vol/vol) glycerol (G20–G50) were labeled with 1 l
blue staining (A) and autoradiography (B) or immunoblot analysis, using m
inset), and ATP in the fractions was determined (D). DIDS-sensitive AT
centrifugation procedure, in a solution containing 100 mM KCl, 0.32 M sucro
ml protein (E). The results are representative of a typical puriﬁcation.with and thus label this putative binding site and hence the
transporter protein, was employed. Irradiation of the SV frac-
tions with [a-32P]BzATP resulted in covalent binding of the
probe to several proteins (Fig. 1(A) and (B)). The labeling pro-
ﬁle of all fractions was similar, i.e., no labeled protein was un-
ique to or enriched in the puriﬁed SVs (40% and 50% glycerol
fractions, Fig. 1(A)–(C)).
The SV membranal fraction isolated following centrifuga-
tion in a glycerol gradient (Fig. 1D, inset, G-40) was found
to be enriched in the SV protein synaptophysin and to also
contain the highest amount of endogenous ATP
(16.9 ± 2.4 pmol, n = 4, ATP/mg protein, Fig. 1(C) and (D)).
ATP transport activity in this fraction showed the highest
DIDS-sensitive ATP accumulation activity measured between
540 and 700 pmol/mg protein (n = 5). To ensure the purity of
the SVs preparation, VDAC, a mitochondrial marker
(Fig. 1(C)), RyR, an ER marker or Na/K ATPase activity, a
plasma membrane marker, were not found in any of the synap-
tic vesicles preparations used for ATP transport experiments
(data not shown). In the subsequent experiments below, SVs
obtained from the 40% glycerol fraction or its equivalent
sucrose (0.2 M) fraction were used.
3.2. Characterization of ATP transport in brain synaptic vesicles
The eﬀect of DIDS and NEM on ATP transport in the SVs
was next tested. Whereas both reagents inhibited ATP trans-
port (Fig. 2), only about 40% of the [a-32P]ATP accumulated
in the SVs was inhibited by pre-incubation with these inhibi-
tors. When the SVs were treated with both inhibitors, noe brain synaptic vesicles (LP2) and glycerol gradient fractions (SVs),
M [a-32P]BzATP and subjected to SDS–PAGE followed by Coomassie
onoclonal anti-synaptophysin or anti-VDAC antibodies ((C) and (D),
P accumulated in the SVs was assayed, using the chromatography–
se, 10 mM K-HEPES, pH 7.4, containing 1 mM [a-32P]ATP and 1 mg/
Fig. 4. Concentration dependent accumulation of [a-32P]ATP in brain
SVs. ATP accumulation activity of the SVs (1 mg/ml) was assayed as in
Fig. 1(D), in the presence of 1 mM [a-32P]ATP and 150 mM KCl. The
data were ﬁtted to the Hill equation (three parameters) and a K0.5 of
1.3 ± 0.3 mM of ATP, a maximal value for ATP accumulated in the
vesicles was 590 ± 40 pmol/mg protein and nH of 2.0 ± 0.17 were
estimated.
Fig. 2. Eﬀect of DIDS and NEM on ATP accumulation in SVs. SVs (1 mg/ml) were incubated for 10 min at room temperature with the indicated
concentration of DIDS (A) or NEM (B) in a solution containing 100 mM KCl, 10 mM K-HEPES, pH 7.4 before the addition of 1 mM [a-32P]ATP.
Control DIDS-sensitive transport activity (100%) was between 540 and 700 pmol/mg protein per 10 min (n = 5).
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transport by these reagents may reﬂect heterogeneity with re-
spect to the vesicle populations. Thus, in subsequent experi-
ments, only DIDS-sensitive ATP transport was considered.
In addition, an excess of non-radioactive ATP was added after
carrying out ATP transport so as to exchange any [a-32P]ATP
externally associated with the vesicles with the non-labeled
substrate.
In such studies, ATP accumulation increased with time,
reaching a maximal accumulation of 530 ± 40 pmols/mg
(n = 5) at steady state (Fig. 3A). ATP accumulation in SVs
was stimulated up to two-fold in the presence of KCl
(Fig. 3(B)). The same stimulatory eﬀect was obtained with
either NaCl, KNO3 or MgCl2 (data not shown), suggesting
that this is not a speciﬁc eﬀect of Cl or K+ ions, but rather
related to ionic strength. EDTA (2 mM) had no eﬀect on
ATP accumulation (not shown). DIDS-sensitive ATP trans-
port in puriﬁed synaptic vesicles, as a function of ATP concen-
tration, showed saturation with half-maximal transport (K0.5)
occurring at 1.3 ± 0.3 mM of ATP and a maximal ATP accu-
mulation of 590 ± 33 pmol/mg protein (Fig. 4). These results
are similar to those reported for the nucleotide uptake activity
of chromaﬃn granules and synaptic vesicles from Torpedo
electric organ [24–26]. A Hill coeﬃcient of 2.0 ± 0.17 (n = 5)
was calculated (Fig. 4). Similar results were again reported
for ATP transport in chromaﬃn granules and for synaptic-like
vesicles from the Torpedo electric organ [27–29].Fig. 3. Time- and KCl-dependence of ATP accumulation in SVs. The time co
as in Fig. 1(D). (B) ATP accumulation activity of the SVs fraction (1 mg/ml)
the indicated concentration of KCl. The data are the means ± S.E.M. of 3 dPurine nucleotides such as AMP, ADP, BzATP, GTP and
the non-hydrolysable analog of ATP, AMP-PNP, each at con-
centration of 2 mM, inhibited 41–52% of the DIDS-sensitive
ATP accumulation (Table 1). CTP, a pyrimidine nucleotide,
also inhibited ATP transport but to a lesser extent (27%).
The eﬀects on ATP transport in brain SVs of several inhib-
itors known to inhibit ATP or neurotransmitter transport inurse of DIDS-sensitive ATP transport in brain SVs (A) was determined
was assayed in the presence of 1 mM [a-32P]ATP and in the presence of
iﬀerent experiments, and were ﬁtted to the Hill equation (nH = 1).
Fig. 5. Eﬀect of diﬀerent inhibitors on ATP accumulation in SVs. ATP
accumulation activity of the SVs (1 mg/ml) was assayed in the presence
of 1 mM [a-32P]ATP following 10 min preincubation with the indi-
cated compounds. The results are the means ± S.E.M. from ﬁve
diﬀerent experiments. Control activity (100%) was 540–610 pmol/
mg protein per 10 min (; P < 0.05,   ; P < 0.001).
Table 1
Eﬀect of diﬀerent nucleotides on ATP accumulation activity in SVs
Nucleotide ATP transport % of control
ATP 59.0 ± 3.1
ADP 58.1 ± 5.3
AMP 50.5 ± 11.0
BzATP 48.4 ± 14.4
GTP 50.0 ± 1.5
CTP 70.7 ± 10.0
AMP-PNP 53.6 ± 21.0
ATP accumulation was assayed as described in Fig. 2, except that the
indicated nucleotide (2 mM) was added. The data are the means
± S.E.M. of 3 to 4 diﬀerent experiments. Control activity (100%) was
between 560 and 615 pmol/mg protein/10 min (P < 0.05).
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(Fig. 5). Atractylosid was shown to inhibit ATP transport in
Torpedo electric organ SVs, in chromaﬃn granules and in
the Golgi apparatus [24,28,32]. By contrast, ATP accumula-
tion in brain SVs was only slightly inhibited by atractylosid
(about 10%, Fig. 5), as was previously demonstrated for
ATP transport in ER [33]. The uptake of acetylcholine,
GABA, glutamate and glycine into the SVs is coupled to H+
eﬄux [34]. However, neither the proton ionophore FCCP
nor baﬁlomycin A (a V-ATPase inhibitor) had any eﬀect on
ATP transport (Fig. 5), although both were shown to inhibit
the accumulation of other neurotransmitters in SVs [35–38].
Thus, ATP transport may be driven by a force other than pro-
ton electrochemical gradient DlH+.4. Discussion
In this study, ATP accumulation in sheep brain synaptic ves-
icles was characterized. The results show that ATP is
transported in synaptic vesicles in a saturable, non-Michae-
lis–Menten manner with a Hill coeﬃcient of 2.0, (Fig. 4) sug-
gesting a complex transport system for ATP loading. Indeed, a
complex two-step curve for e-ATP transport into brain SVs
was postulated previously [26]. Baﬁlomycin A, a speciﬁcV-ATPase inhibitor, and FCCP, a proton ionophore, were pre-
viously shown to inhibit the uptake of neurotransmitters by SVs
[35–38]. By contrast, our results show that neither compound
aﬀected ATP transport in brain SVs (Fig. 5). These observa-
tions, together with the ﬁnding that ATP is not transported
against its concentration gradient (see below), suggests that a
DlH+ driving force is not required for this ATP transport.
The calculated maximal concentration of ATP in the SVs,
using a value of 600 pmol/mg protein (obtained under the opti-
mal conditions 10 mM ATP, 100 mM KCl, pH 7.4) and
assuming an intra-vesicular volume of 0.1–1.0 ll/mg protein
[10], was found to be 0.6–6 mM. This concentration is similar
to that used in transport assays, suggesting that ATP is not
accumulated against its concentration gradient. Moreover,
although no data indicating the existence of SV that do not
contain ATP have been presented, it is likely that not all syn-
aptic vesicles accumulate ATP. Indeed, it is assumed that
about 15% of brain SVs are cholinergic vesicles, known to con-
tain ATP. Taking this into account, the calculated ATP con-
centrations within the SVs now range between 5 and 50 mM.
While these concentrations are lower than those reported for
the almost exclusively cholinergic Torpedo SVs, they would
allow for the synaptic release of ATP to the synaptic cleft to
occur down a favorable gradient.
Thus, the measured brain SV ATP transport may represent
passive ATP transport into the vesicles involving either a chan-
nel-like activity or facilitated diﬀusion mediated by a carrier. If
the ATP transport measured is mediated by a carrier, this pro-
tein should possess an ATP binding site. However, eﬀorts to
identify [a-32P]BzATP-labeled protein(s) whose labeling would
gradually increased with SV puriﬁcation were not successful
(Fig. 1). Still, the existence of such a carrier could not be ruled
out, as its expression in the whole brain SVs preparation may
be very low.
Based on our observations, we propose that ATP is trans-
ported into SVs along its concentration gradient. One possible
system for such concentration gradient could be a direct trans-
port from its synthesis site, the mitochondria, where local high
[ATP] could be transported to the synaptic vesicles with its
concentration gradient.
This proposed transporter-based mechanism for SV ATP
loading in mitochondrial membrane may also serve for loading
ATP into other organelles such as in ER [33] or Golgi [32].
Indeed, in the case of Ca2+ transport, accumulating evidence
supports mitochondria-ER communication, where Ca2+ moves
directly between the two organelles without passing through
the cytosol [39,40]. The involvement of VDAC, a channel
transporting ATP, at the mitochondria-ER cross-talk has been
suggested [41]. Thus, although further experimentation is
required to verify this hypothesis, it can be speculated that a
similar mechanism for ATP movement directly from mito-
chondria into the synaptic vesicles exists. Our ﬁnding that
ATP loading channels and/or transporters are present in vesi-
cular membranes may suggest that these proteins will also be
present in plasma membrane for at least a brief period of time,
where they could release ATP down a very favorable gradient
directed out of the cell.References
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